Skip to main content
Medical information Clinical review pending

Genetic Testing

Fungal Genome De Novo Assembly and Annotation Illumina

This advanced genetic test analyzes the complete genetic sequence of fungal organisms to identify species and characteristics, aiding in diagnosis and targeted treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Confirm with the laboratory before booking. Typically requires a sample of the fungal culture or tissue.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Specific preparation instructions may depend on the sample type.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Fungal Genome De Novo Assembly and Annotation Illumina test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained or persistent infections suspected to be fungal
  • ✓Identification of specific fungal strains
  • ✓Patients with compromised immune systems
  • ✓Monitoring treatment response in fungal infections
  • ✓Research purposes
02

In plain language

What this test helps you understand

Provides comprehensive genetic information about fungal organisms, aiding in species identification, understanding pathogenicity, and guiding targeted treatment strategies.
The Fungal Genome De Novo Assembly and Annotation Illumina test is a sophisticated diagnostic tool used to comprehensively analyze the genetic makeup of fungi. Using advanced sequencing technology, this test provides detailed insights into fungal genetics, which is vital for understanding their behavior, potential to cause disease (pathogenicity), and how they respond to treatment. This test is particularly relevant given the increasing prevalence of fungal infections and the need for precise identification.

This test measures the complete genetic sequence of fungal organisms. This allows for the identification of specific fungal strains and their unique characteristics. It can help detect genetic variations that might influence how the fungus responds to medication and its ability to cause illness.

Individuals who might benefit from this test include those experiencing persistent or unexplained infections, people with weakened immune systems who are more susceptible to fungal infections, and healthcare providers needing to identify specific fungal strains for effective treatment strategies.

Benefits of this test include accurate identification of fungal species, which allows for more targeted and effective therapies. It also provides insights into genetic factors that could influence treatment success and helps in monitoring and managing fungal infections more effectively.

Results will detail the specific fungal strains identified and their genetic characteristics. It is important to discuss these results with your doctor to understand their meaning for your health and treatment plan.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Specific preparation instructions may depend on the sample type.
SampleConfirm with the laboratory before booking. Typically requires a sample of the fungal culture or tissue.
MethodologyIllumina sequencing platform for de novo genome assembly and annotation.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes the genetic material of the fungus present in the sample. It may not detect all fungal species or strains, especially if present in low numbers. Results interpretation requires expertise in mycology and genetics. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

De novo assembly means building a genome sequence from scratch, without relying on a pre-existing reference genome for that specific fungus.
Different strains of the same fungus can have varying levels of virulence (ability to cause disease) and different sensitivities to antifungal medications.
This is a highly specialized test typically used for complex, difficult-to-diagnose, or research-related fungal infections, not usually for common fungal infections.
Results are typically interpreted by specialists, often in collaboration with your treating physician, to determine the clinical significance.
Annotation involves identifying the functions of different genes within the assembled genome, providing insights into the fungus's biology and potential virulence factors.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp